- Aerosol transmission of prions is experimentally confirmed (PMC3020930), raising the specter of “very slow biowarfare” and prompting discussion of whether monoclonal-antibody or small-molecule therapies could neutralize specific prion strains.  
- Immunotherapy papers (PMC7157205) show that anti-PrP antibodies can reduce peripheral PrPSc loads and curb shedding in chronic wasting disease, but the blood–brain barrier blocks most antibodies, leaving CNS infections largely untreatable.  
- Participants debate whether lifelong small-molecule drugs that disable prion autocatalysis could render infected tissue safe for consumption, versus the counter-argument that no known cooking protocol denatures prions enough to eliminate infectivity.  
- Cellbricks.com (a 3-D bioprinting startup) is floated as a potential employer, indicating growing commercial interest in organ-on-chip and tissue-engineering platforms.  
- Tokyo 2020 Olympic drone light shows are described as “true volumetric displays,” with parallel research noted on sonic-levitation particle traps illuminated by lasers for even finer 3-D imagery.